pDNA/rVSV vector vaccine (Auro vaccines)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamepDNA/rVSV vector vaccine (Auro vaccines)
Drug Alias NamepDNA/rVSV vector vaccine (Profectus)plasmid DNA/recombinant vesicular stomatitis virus vector vaccine (Profectus)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesWyeth Pharmaceuticals Co
China Registration ClassN/A

Develop Information

Active CompaniesAuro Vaccines Llc
Inactive Companies +[1]  N/A
Active IndicationsHerpes Simplex Virus Type 2 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A